The Peptide
Benchmark
Independent vendor reviews, deep-dive peptide guides, and aggregated research — all in one place. No fluff, no bias, just data.
Vendor Benchmark Rankings
Source-linked benchmark records blended from Finnrick and Peptide Critic when both exist, then normalized onto a shared 10-point benchmark scale and ordered by a confidence-weighted rank score.
Finnrick sync: Mar 17, 2026, 1:24 AM. Peptide Critic sync: Mar 17, 2026, 12:48 AM. Showing 4 of 221 scoreable vendors from a 239-entry merged dataset.
Vendors currently scored by both Finnrick and Peptide Critic.
Entries with enough source depth to keep most of their raw benchmark signal.
Combined Finnrick test records and Peptide Critic reviews informing the board.
EZ Peptides
EZ Peptides is currently our only disclosed referral partner, so it gets an explicit PeptideBenchmark pick label. That badge is editorial and separate from the source-derived benchmark data shown below.
Benchmark score is the normalized source score. Rank score is the confidence-weighted ordering value. The signal bar and evidence count help show how much underlying data is holding each card up.
- No Finnrick test coverage yet
- 28 Peptide Critic reviews captured
- United States
- 17 Finnrick test records tracked
- 23 Peptide Critic reviews captured
- United States
- 40 Finnrick test records tracked
- 15 Peptide Critic reviews captured
- United States
- 47 Finnrick test records tracked
- 6 Peptide Critic reviews captured
- United States
Peptides by Category
Explore peptides organized by their primary function. Each category includes comprehensive profiles, dosing guides, and comparison charts.
Trending Peptides
Current profile coverage pulled directly from the peptide collection, mixing FDA-approved medicines with closely watched research compounds.
Peptide News Wire
FDA.gov FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s 13 days ago PubMed Retatrutide in type 2 diabetes mellitus and obesity: an overview. 7 days ago ClinicalTrials.gov A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) 8 days ago FDA.gov FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs 38 days agoFrom the Blog
Collection-backed notes on benchmark methodology, source quality, and how to interpret peptide vendor signal without overclaiming certainty.
A disclosed first-person writeup covering shipping speed, product experience, BAC water convenience, and whether EZ Peptides feels worth the premium.
A practical starting point for understanding peptide categories, vendor noise, evidence quality, and the biggest mistakes beginners make.
A transparent walkthrough of how PeptideBenchmark combines Finnrick and Peptide Critic into one ranked board.